Oncological Endocrinology Unit, Department of Medical Sciences, Città della Salute e della Scienza Hospital, Turin, Italy.
Endocrinology and Metabolic Diseases Unit, AO SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
Front Endocrinol (Lausanne). 2021 Jan 26;11:610230. doi: 10.3389/fendo.2020.610230. eCollection 2020.
Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis and treatment, our knowledge is still really uncertain. In the present short review of the medical literature on this topic, we have evaluated in details their epidemiology, risk factors, pathogenesis, pathology, clinical presentation, radiographic aspects, prognosis, and therapy. We have thus been able to identify a number of open issues regarding primary neuroendocrine neoplasms of the breast that need to be clarified. Our ultimate aim was actually to try to understand whether neuroendocrine neoplasms of the breast can be considered a definite clinical entity and if neuroendocrine differentiation of breast tumors has a really clinical relevance.
神经内分泌乳腺肿瘤是一种罕见的乳腺癌亚型,占所有神经内分泌肿瘤的不到 1%。从它们的病理定义,到它们的流行程度、预后和治疗,我们的认识仍然非常不确定。在对该主题的医学文献进行的简短综述中,我们详细评估了它们的流行病学、危险因素、发病机制、病理学、临床表现、影像学表现、预后和治疗。因此,我们能够确定一些关于乳腺原发性神经内分泌肿瘤的未解决问题,需要进一步澄清。我们的最终目的实际上是试图了解乳腺神经内分泌肿瘤是否可以被认为是一种明确的临床实体,以及乳腺肿瘤的神经内分泌分化是否具有真正的临床相关性。